U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07226934) titled 'An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers' on Nov. 07.
Brief Summary: The goal of this study is to evaluate the feasibility and preliminary efficacy of an artificial intelligence (AI)-generated personalized question prompt list (a list of suggested questions to ask during outpatient appointments) for patients with hematologic cancers. The intervention will involve tailoring a standardized prompt to patients' individual characteristics and concerns. This prompt will then be used to ask Washington University's (WashU) HIPAA compliant ChatGPT to generate personalized question ...